Get the tools used by (smart)2 investors.

NOPAT Forecast CAGR (2y)

Join now and get access to the full platform

Search for company or ETF

 

  0 results available. Select is focused ,type to refine list, press Down to open the menu,

-
Price
Fair Value
Upside
- - -
52-week range

Analysis

Fiscal Years
Trailing Twelve Months
Fiscal Halfs
Fiscal Quarters
Daily
Hide this widget

Benchmarks

Hide this widget

No data available

Metric Usage

Hide this widget

No data available

Similar Metrics

Hide this widget

No data available

Search for metric or datapoint

Definition of NOPAT Forecast CAGR (2y)

Hide this widget

No data available

Sector Benchmark Analysis

Sector
Industry Group
Industry
Hide this widget
-11.9%8.1%28.1%55.4%0204060

The chart above depicts the distribution of nopat forecast cagr (2y) for companies operating in the Healthcare sector in the Developed economic region. Over 290 companies were considered in this analysis, and 286 had meaningful values. The average nopat forecast cagr (2y) of companies in the sector is 8.2% with a standard deviation of 11.0%.

Bayer AG's NOPAT Forecast CAGR (2y) of -47.7% is significantly outside the interquartile range and is excluded from the distribution. The following table provides additional summary stats:

NOPAT Forecast CAGR (2y) In The Healthcare Sector
Economic Risk RegionDeveloped
Total Constituents297
Included Constituents286
Min-15.2%
Max51.6%
Median6.7%
Mean8.2%
Standard Deviation11.0%

You can find companies with similar nopat forecast cagr (2y) using this stock screener.

All rights reserved. Terms Of Use